Shared Medical Appointments for Substance Use Disorders: A Systematic Review
- 13 July 2026
- journal article
- review article
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 47 (4) , 1288-1296
Abstract
Background: Shared medical appointments (SMAs) integrate group-based clinical care with individual medical management and are increasingly used in the treatment of substance use disorders (SUDs) to improve access, engagement, and care coordination. However, their use, outcomes, and implementation in SUD care have not been systematically synthesized. Methods: We conducted a systematic review registered with PROSPERO (CRD42025639504). MEDLINE, Embase, PsycINFO, Scopus, and Cochrane Central were searched from database inception through September 2025. Randomized controlled trials, observational studies, and qualitative studies examining SMAs among adults with SUDs were included. Outcomes of interest included treatment engagement and retention, substance use outcomes, mental health and patient-reported outcomes, and implementation characteristics. Study quality was assessed across quantitative and qualitative designs, and findings were synthesized descriptively. Results: Fourteen studies, representing approximately 578 participants, met inclusion criteria. Twelve studies focused exclusively on opioid use disorder, 1 included both alcohol and opioid use disorders, and 1 did not specify substance type. Treatment retention was reported in 6 studies, with a median 6-month retention of 72.9%. Three studies reported reductions in substance use outcomes, and 2 reported improvements in depression or anxiety. Qualitative studies consistently described high patient satisfaction, peer support, and shared accountability. Implementation studies demonstrated feasibility across diverse outpatient settings, with substantial heterogeneity across study designs and outcomes. Conclusions: SMAs appear feasible and acceptable for addiction care and may support treatment retention and patient experience. Evidence remains heterogeneous and largely observational, highlighting the need for rigorous comparative studies to better define effectiveness and implementation.Keywords
This publication has 25 references indexed in Scilit:
- Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and preventionWorld Psychiatry, 2023
- Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world dataInternational Journal of Methods in Psychiatric Research, 2022
- Barriers to retention in substance use treatment: Validation of a new, theory-based scaleJournal of Substance Abuse Treatment, 2021
- Abstracts from the 2020 Annual Meeting of the Society of General Internal MedicineJournal of General Internal Medicine, 2020
- Implementing Group Visits for Opioid Use Disorder: A Case SeriesSubstance Abuse, 2020
- Improving the content validity of the mixed methods appraisal tool: a modified e-Delphi studyJournal of Clinical Epidemiology, 2019
- Why use Group Visits for Opioid use Disorder Treatment in Primary Care? A Patient-Centered Qualitative StudySubstance Abuse, 2018
- Buprenorphine Shared Medical Appointments for the Treatment of Opioid Dependence in a Homeless ClinicSubstance Abuse, 2017
- Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment with Buprenorphine: A Pilot StudySubstance Abuse, 2015
- Drop-out from addiction treatment: A systematic review of risk factorsClinical Psychology Review, 2013